Financial Results
Presentation for Fiscal 2021
May 13, 2022
Kensuke Kondo,
President and
Representative Director
Overview of Fiscal 2021
Financial Results
2
10-Year Earnings History
Significant increase in tests related to COVID-19
(Millions of yen)
FY2021
3
Year-on-Year Comparison
(Millions of yen)
FY2020 | FY2021 | YoY | Change | |
Net sales | 138,571 | 186,067 | 47,495 | 34.3% |
Testing business | 132,911 | 179,751 | 46,840 | 35.2% |
Clinical testing business | 128,612 | 175,232 | 46,620 | 36.2% |
Other testing business | 4,299 | 4,519 | 220 | 5.1% |
Medical informatics business | 4,214 | 4,816 | 602 | 14.3% |
Other businesses | 1,445 | 1,498 | 52 | 3.7% |
Operating income | 19,936 | 48,889 | 28,953 | 145.2% |
Ordinary income | 20,803 | 51,077 | 30,273 | 145.5% |
Profit attributable to owners of | 13,711 | 33,741 | 20,029 | 146.1% |
parent | ||||
4
Breakdown of Changes in Sales by Business Segment
Net sales up 47,495m (34.3%) YoY
(Millions of yen)
+220 | +655 | |
+46,620 | Food hygiene | Medical |
business, etc. | informatics | |
business, | ||
Clinical | other businesses | |
testing | ||
business |
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
BML Inc. published this content on 13 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 June 2022 23:11:08 UTC.